Sign in

CIK 0001861123 · <br>Emerging growth company

Eikon Therapeutics, Inc.

Sign in to watch
Ticker
EIKN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
842807586
Phone
341-777-0566
Business address
230 HARRIET TUBMAN WAY, MILLBRAE, CA, 94030
  1. 4 Open-market buy 10% owner bought 89,200 shares at $11.56 ($1,031,045)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Conversion See remarks acquired 284,857 shares (conversion)
  11. 4 Open-market buy 10% owner bought 2,117,760 shares at $18.00 ($38,119,680)
  12. 4 Open-market buy 10% owner bought 55,555 shares at $18.00 ($999,990)
  13. 4 Open-market buy Director bought 111,111 shares at $18.00 ($1,999,998)
  14. 4 Open-market buy Director bought 277,776 shares at $18.00 ($4,999,968)
  15. 4 Open-market buy 10% owner bought 277,776 shares at $18.00 ($4,999,968)
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 1 of 2 · 28 filings